Clinical Trial Update: Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination of liposomal doxorubicin, vincristine, and dexamethasone plus arsenic trioxide in untreated symptomatic multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Doxil (liposomal doxorubicin)
• Oncovin (vincristine)
• Trisenox (arsenic trioxide)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED